Publicaciones en colaboración con investigadores/as de University of Milano-Bicocca (10)

2023

  1. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

    Nature Communications, Vol. 14, Núm. 1

  2. Prussian Blue nanoparticles: An FDA-approved substance that may quickly degrade at physiological pH

    Colloids and Surfaces B: Biointerfaces, Vol. 227

  3. Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis

    Blood, Vol. 141, Núm. 21, pp. 2615-2628

2021

  1. Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study

    Modern Pathology, Vol. 34, Núm. 1, pp. 59-69

2019

  1. Experimental models to unravel the molecular pathogenesis, cell of origin and stem cell properties of cholangiocarcinoma

    Liver International, Vol. 39, Núm. S1, pp. 79-97

  2. P65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1

2018

  1. Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia

    Leukemia, Vol. 32, Núm. 4, pp. 874-881

2017

  1. AAV-PHP.B-Mediated Global-Scale Expression in the Mouse Nervous System Enables GBA1 Gene Therapy for Wide Protection from Synucleinopathy

    Molecular Therapy, Vol. 25, Núm. 12, pp. 2727-2742

  2. Annexin A5 in treated hypertensive patients and its association with target organ damage

    Journal of Hypertension, Vol. 35, Núm. 1, pp. 154-161

2015

  1. Immunosurveillance of the liver by intravascular effector CD8+ T cells

    Cell, Vol. 161, Núm. 3, pp. 486-500